Skip to content

Fulgent Genetics, Inc. FLGT Short-Term Investments

Short-Term Investments at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$912M+0.6%
GeneDx Holdings logo
GeneDx HoldingsWGS
$76.76M+29.1%
Personalis, Inc. logo
Personalis, Inc.PSNL
$159.62M+39.2%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$1.01B-14.1%
Azenta logo
AzentaAZTA
$146.48M
Illumina logo
IlluminaILMN
$66M-46.8%

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$552.11M-7.1%
Enterprise value$536.92M+0.7%
P/S1.7×-0.3×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.

The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s short-term investments?
Fulgent Genetics, Inc. (FLGT) reported short-term investments of $252.9M in Q1 2026.
What is the long-term trend for Fulgent Genetics, Inc.'s short-term investments?
Over 2 years (2020 to 2025), Fulgent Genetics, Inc.'s short-term investments has grown at a 16.1% compound annual growth rate (CAGR), from $211.94M to $285.88M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.